Arthur Mikaelian
Chief Executive Officer at QUANTA
Net worth: - $ as of 30/07/2022
Profile
Arthur Grant Mikaelian is the founder of Medolife Corp.
(founded in 2004) where he holds the title of Chairman, President & Chief Executive Officer.
He is also the founder of Medolife Rx, Inc. (founded in 2007) where he holds the title of President & Chief Executive Officer.
Dr. Mikaelian's current job(s) include being the President & Chief Executive Officer at PetLife Corp.
and the Chairman, President, Chief Executive Officer & CFO at Quanta, Inc. (since 2021).
Dr. Mikaelian's former job includes being the President, Chief Executive Officer & Director at Petlife Pharmaceuticals, Inc.Dr. Mikaelian's education history includes an MBA from Alma Mater Studiorum - Università di Bologna and a doctorate from Taurida National V I Vernadsky University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
13/04/2021 | 9,000 ( 100.00% ) | - $ | 30/07/2022 | |
QUANTA INC PFD A
100.00% | 01/06/2021 | 2,500,000 ( 100.00% ) | - $ | 30/07/2022 |
Arthur Mikaelian active positions
Companies | Position | Start |
---|---|---|
QUANTA | Chief Executive Officer | 13/01/2021 |
PetLife Corp. | Chief Executive Officer | - |
Medolife Corp.
Medolife Corp. Information Technology ServicesTechnology Services Part of Quanta, Inc., Medolife Corp. is a company that specializes in polarization technology. The company is based in Beverly Hills, CA. Dr. Mikaelian's technical education began in Russia and Italy, where he earned his doctorate in biological psychology and an MBA from the University of Bologna. For more information, visit their website or contact them at info@medolife.com. The company was founded in 2004 by Arthur Grant Mikaelian, who has been the CEO since then. Medolife Rx, Inc., a Wyoming corporation, was founded by Dr. Arthur Mikaelian and has been awarded a patent for polarized scorpion venom solution and the method for making it. Medolife was acquired by Quanta, Inc. on January 14, 2021. | Chief Executive Officer | 31/12/2003 |
Medolife Rx, Inc.
Medolife Rx, Inc. Pharmaceuticals: MajorHealth Technology Part of Quanta, Inc., Medolife Rx, Inc. produces and supplies pharmaceuticals and nutraceuticals. The company is based in Beverly Hills, CA. The company was founded in 2007 by Arthur Grant Mikaelian, Armani Minasyan. Arthur Grant Mikaelian has been the CEO since 2007. | Chief Executive Officer | 31/12/2006 |
Former positions of Arthur Mikaelian
Companies | Position | End |
---|---|---|
PETLIFE PHARMACEUTICALS, INC. | Chief Executive Officer | - |
Training of Arthur Mikaelian
Alma Mater Studiorum - Università di Bologna | Masters Business Admin |
Taurida National V I Vernadsky University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PETLIFE PHARMACEUTICALS, INC. | Health Technology |
QUANTA | Electronic Technology |
Private companies | 3 |
---|---|
Medolife Rx, Inc.
Medolife Rx, Inc. Pharmaceuticals: MajorHealth Technology Part of Quanta, Inc., Medolife Rx, Inc. produces and supplies pharmaceuticals and nutraceuticals. The company is based in Beverly Hills, CA. The company was founded in 2007 by Arthur Grant Mikaelian, Armani Minasyan. Arthur Grant Mikaelian has been the CEO since 2007. | Health Technology |
PetLife Corp. | |
Medolife Corp.
Medolife Corp. Information Technology ServicesTechnology Services Part of Quanta, Inc., Medolife Corp. is a company that specializes in polarization technology. The company is based in Beverly Hills, CA. Dr. Mikaelian's technical education began in Russia and Italy, where he earned his doctorate in biological psychology and an MBA from the University of Bologna. For more information, visit their website or contact them at info@medolife.com. The company was founded in 2004 by Arthur Grant Mikaelian, who has been the CEO since then. Medolife Rx, Inc., a Wyoming corporation, was founded by Dr. Arthur Mikaelian and has been awarded a patent for polarized scorpion venom solution and the method for making it. Medolife was acquired by Quanta, Inc. on January 14, 2021. | Technology Services |
- Stock Market
- Insiders
- Arthur Mikaelian